Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report  Egidio Del Fabbro, MD, David Hui, MD, Zohra I. Nooruddin, MD, Shalini Dalal, MD, Rony Dev, MD, Gina Freer, RN, Lynn Roberts, RN, J. Lynn Palmer, PhD, Eduardo Bruera, MD  Journal of Pain and Symptom Management  Volume 39, Issue 6, Pages 1016-1024 (June 2010) DOI: 10.1016/j.jpainsymman.2009.09.021 Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 A) Survival analyses (Kaplan-Meier) with comparisons of curves by the log rank test. Survival of male patients with testosterone levels ≤185ng/dL (blue) was decreased compared with that of those with levels >185ng/dL (green). B) Survival analyses (Kaplan-Meier) of men and women with CRP done within 30 days of consultation and with comparisons of curves by the log rank test. Patients with CRP levels >10mg/L (green) had decreased survival compared with those with levels ≤10mg/L (blue). C) Survival analyses (Kaplan-Meier) of male patients with both testosterone and CRP done within 30 days of consultation, with comparisons of curves by log rank test. Patients with a combination of low testosterone and high CRP levels (green) had significantly decreased survival compared with other patients (blue). MS=median survival. Journal of Pain and Symptom Management 2010 39, 1016-1024DOI: (10.1016/j.jpainsymman.2009.09.021) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions